Who owns Cytospire Therapeutics?

Cytospire Therapeutics is currently owned by 4Bio Partners, through 4BIO Ventures III, since 2026.

When did 4Bio Partners acquire Cytospire Therapeutics?

4Bio Partners acquired Cytospire Therapeutics in 2026 (active for 0 years).

Home/Companies/Biotech/Cytospire Therapeutics

Cytospire Therapeutics

Biotech·

UK·Active·0yr hold

Cytospire Therapeutics is a biotech company, headquartered in UK.

Entry

2026

Hold

0yr

Status

Active

Est. EV

–

Investor

4Bio Partners

Key facts

HQUK

SectorBiotech

StatusActive

UK biotechnology company developing pan-gamma delta T cell engager antibodies for cancer; 4BIO Capital led its 2026 Series A financing.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from 4BIO Ventures III

Other portfolio companies in the same fund.

More PE-backed in Biotech

Comparable biotech deals from other GPs.

AdBio PartnersBelgium

Last updated May 2026 · Sourced from public filings